ALTHealthcare
Altimmune Inc (ALT) Insider Trading
In the last 90 days, 1 Altimmune Inc (ALT) insider reported 1 open-market purchase totaling $44,250 and no sales. The most recent open-market purchase was reported on Aug 13, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 1
- 90-day purchase value
- $44,250
- Corporate buyers
- 1
- Latest transaction
- Aug 13, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
ALT insider trading FAQ
- Are ALT insiders buying or selling?
- Over the last 90 days, ALT insiders were net buyers, reporting $44,250 of open-market purchases and $0.00 of sales.
- When was the last ALT insider purchase?
- The most recent open-market purchase of Altimmune Inc stock by an insider was reported on Aug 13, 2026, one of 1 purchase in the last 90 days.
- Where does ALT insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Altimmune Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Healthcare
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp69 filings
- TWST insider tradingTwist Bioscience Corp37 filings
- TEM insider tradingTempus AI Inc24 filings
- NTRA insider tradingNatera Inc22 filings
- CORT insider tradingCorcept Therapeutics Inc20 filings
- CSTL insider tradingCastle Biosciences Inc20 filings
- CLOV insider tradingClover Health Investments Corp18 filings
- MEDP insider tradingMedpace Holdings Inc18 filings
